LIJEČENJE DJEČJE AKUTNE LIMFOBLASTIČNE LEUKEMIJE SA BISPECIFIČNIM PROTUTIJELIMA PROTIV CD3XCD19

• 收藏
• 分享

专利权人:

Amgen Research (Munich) GmbH

发明人:

Zugmaier, Gerhard

申请号：

HRP20191715

公开号：

HRP20191715T1

申请日:

2019.09.20

申请国别(地区):

HR

年份:

2019

代理人:

摘要：

The present invention relates to a method for the treatment, amelioration or elimination of pediatric acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19xCD3 bispecific single chain antibody construct to a pediatric ALL patient in the need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/